Response to Wiwanitkit et al. comment on the report: ‘A randomised trial investigating the safety and efficacy of influenza vaccination in patients with ANCA‐associated vasculitis’

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|8|584-584

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.8, 2015-08, pp. : 584-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody‐associated vasculitis

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 343-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c89-c97

Karger

Access to resources Recommend Favorite

Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c182-c188

Karger

Access to resources Recommend Favorite

Phosphorylcholine antibodies are diminished in ANCA‐associated vasculitis

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 686-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD14 expression is increased on monocytes in patients with anti‐neutrophil cytoplasm antibody (ANCA)‐associated vasculitis and correlates with the expression of ANCA autoantigens

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 65-75

John Wiley & Sons Inc

Access to resources Recommend Favorite